We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.95
Bid: 19.50
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 1.50 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 19.95
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Production update

3 Apr 2017 07:00

RNS Number : 2741B
Iofina PLC
03 April 2017
 

 

3 April 2017

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Production update

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, today provides an update to the market regarding its current iodine production and outlook.

 

Recently the Company was notified that the injection volumes at the Salt Water Disposal Well (''SWD'') operated by our partner at the site of IOsorb® plant IO#3 will be reduced. This will impact the availability of brine to our IO#3 plant. In response to this issue, Iofina is working with our partner to investigate alternative brine supply opportunities at this location. In addition to alternative brine delivery options at the existing location, the Company is also analysing reutilization of IO#3 resources at new sites within our core iodine production area. Iofina's exploration program has researched several potential sites that the Company believes will deliver iodine rich brine streams.

 

IO#3 in 2017 has been our lowest iodine producing IOsorb® plant with relatively high production cost. Location of these resources at one of the new sites the Company is investigating would be expected to significantly increase iodine production and lower our per kilo cost.

 

After reassessing the currently anticipated 2017 performance of all our plants, the Company has concluded that the reduction of brine at IO#3 will have only a small impact on the Company's forecast production. Accordingly, the Company now expects to produce between 215-230 MT of crystalline iodine in H1 2017. Additionally, the Company anticipates that this reduction in available brine will have little impact on the Company's planned net cashflow. Iofina will update the market accordingly once we have analysed options and finalized plans for utilization of IO#3.

 

Commenting, President and CEO Dr. Tom Becker, stated: 

 

''The reduction in available brine at IO#3 is likely to provide opportunities for us to source an alternative brine supply at the current location or it will accelerate our plans for a new iodine production location. Execution of plans to produce iodine at a new location would lead to increased iodine output rates versus the Company's production rate at the end of 2016, and reduce the Company's overall iodine production costs. We look forward to updating the market once plans are finalised. " 

 

 

Enquiries:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

 

 

Christopher Raggett/Giles Rolls/Emily Morris

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7544 275 882

 

 

 

About Iofina:

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDMMGGDRZLGNZM
Date   Source Headline
22nd Mar 20107:00 amRNSRe Iodine Extraction and Collection Agreement
8th Mar 20107:02 amRNSOperations Update
8th Mar 20107:00 amRNSManagement changes
12th Jan 20103:09 pmRNSDirectorate Change
8th Jan 20107:00 amRNSDirector's Dealings
11th Dec 20096:00 pmRNSHolding in Company
22nd Oct 20095:14 pmRNSChange of Name of Nominated Adviser
19th Oct 20094:07 pmRNSExercise of Options
30th Sep 20097:00 amRNSHalf Yearly Report
10th Aug 200911:13 amRNSManagement Appointments
27th Jul 20097:00 amRNSAcquisition and Operations Update
23rd Jun 200910:20 amRNSResult of AGM
22nd Jun 20094:40 pmRNSSecond Price Monitoring Extn
22nd Jun 20094:35 pmRNSPrice Monitoring Extension
27th May 20094:19 pmRNSPosting of Annual Report
12th May 20097:00 amRNSFinal Results
25th Feb 20099:57 amRNSHolding(s) in Company
23rd Feb 20091:55 pmRNSHolding(s) in Company
19th Feb 200911:06 amRNSDirector/PDMR Shareholding
12th Feb 20094:44 pmRNSPlacing
13th Jan 20097:00 amRNSDirectorate Change
13th Jan 20097:00 amRNSDrilling Update
19th Dec 20085:00 pmRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSOperational Update
7th Nov 20089:59 amRNSHolding(s) in Company
31st Oct 200810:53 amRNSDirector/PDMR Shareholding
30th Oct 20083:39 pmRNSHolding(s) in Company
16th Sep 20085:26 pmRNSDirector/PDMR Shareholding
16th Sep 20084:28 pmRNSDirector/PDMR Shareholding
12th Sep 20085:03 pmRNSDirectorate Change
9th Sep 20087:00 amRNSAppointment of Non Executive
9th Sep 20087:00 amRNSInterim Results
13th Aug 20087:00 amRNSAcquisition
25th Jul 20085:10 pmRNSHolding(s) in Company
16th Jul 20087:00 amRNSOperations Update
10th Jun 20081:29 pmBUSRule 8.3 - INFORMA PLC
9th May 20087:00 amRNSPlacing and Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.